May 04, 2022 6:32 AM ETG1 Therapeutics, Inc. (GTHX)By: Meghavi Singh, SA News Editor G1 Therapeutics press release (NASDAQ:GTHX): Q1 GAAP EPS of -$1.15 misses by $0.17. Revenue of $6.9M (-51.5% Y/Y) beats by $0.78M. Ended the Q1 with Cash and Cash Equivalents of $183.0 Million: The Company’s current financial position is expected to be sufficient to fund G1’s operations and capital expenditures into 2024.
|